NCCN Guidelines for Patients® | Myeloproliferative Neoplasms

3 NCCN Guidelines for Patients ® : Myeloproliferative Neoplasms, 2018 Supporters Endorsed and sponsored in part by MPN Research Foundation The NCCN guidelines for myelofibrosis provide clarity for physicians and patients about their options and what to expect upon diagnosis with PV, ET or MF. These are long awaited by the patient community and we are so glad to see it come to fruition. Endorsed by Leukemia & Lymphoma Society LLS is dedicated to developing better outcomes for blood cancer patients through research, education and patient services and is happy to have this comprehensive resource available to patients. MPN Cancer Connection MPN Cancer Connection (MPN-CC) recognizes MPN patients are in fact “cancer patients” and should have full access to programs, benefits and resources available in your area. MPN-CC is pleased to support the comprehensive resource provided by the NCCN Patient Guidelines for Myeloproliferative Neoplasms (MPNs). MPN Education Foundation Educating physicians and patients about evidence-based diagnostic algorithms and treatment for the myeloproliferative neoplasms will benefit both, and will improve patient access to those treatments. The MPN Education Foundation is pleased to endorse this landmark effort on behalf of those we serve.